Research from the TIMELESS and CHABLIS-T II trials indicated that using Tenecteplase (TNK) can be safe in an extended window of 4.5 to 24 hours for specific patients, though further study on functional outcomes is needed.
1-year outcomes from the SELECT2 trial confirmed that endovascular thrombectomy significantly improves long-term functional outcomes for patients with large ischemic strokes. World Stroke Day 2024: #GreaterThanStroke
The #GreaterThanStroke Active Challenge leveraged the "emotional power of sport" to encourage daily physical activity as a primary prevention tool. stroke2024
Beyond the ISC, the year was marked by other major international assemblies: 16th World Stroke Congress (WSC 2024)
Public education continued to prioritize the FAST acronym—Face drooping, Arm weakness, Speech difficulty, and Time to call emergency services. Global Academic Gatherings Research from the TIMELESS and CHABLIS-T II trials
The ZODIAC trial found that zero-degree (flat) head positioning is safe and improves outcomes for patients with large vessel occlusions awaiting thrombectomy, compared to the traditional 30-degree elevation.
In 2024, the global medical and advocacy communities centered their "stroke2024" efforts on groundbreaking clinical research and a high-energy awareness campaign under the theme . Major Clinical Highlights (ISC 2024) Beyond the ISC, the year was marked by
The Fast AI smartphone app demonstrated accuracy comparable to neurologists in detecting acute stroke signs using machine learning algorithms on audio and video recordings.